Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 1;58(12):1775.
doi: 10.3390/medicina58121775.

Intact Fish Skin Graft vs. Standard of Care in Patients with Neuroischaemic Diabetic Foot Ulcers (KereFish Study): An International, Multicentre, Double-Blind, Randomised, Controlled Trial Study Design and Rationale

Dured Dardari  1   2 , Louis Potier  3   4 , Ariane Sultan  5   6 , Maude Francois  7 , Jocelyne M'Bemba  8 , Benjamin Bouillet  9   10 , Lucy Chaillous  11 , Laurence Kessler  12 , Aurelie Carlier  3 , Abdulkader Jalek  5 , Ayoub Sbaa  12 , Laurent Orlando  13 , Elise Bobony  13 , Bruno Detournay  14 , Hilmar Kjartansson  15 , Ragna Bjorg Arsaelsdottir  15 , Baldur Tumi Baldursson  15 , Guillaume Charpentier  13
Affiliations

Intact Fish Skin Graft vs. Standard of Care in Patients with Neuroischaemic Diabetic Foot Ulcers (KereFish Study): An International, Multicentre, Double-Blind, Randomised, Controlled Trial Study Design and Rationale

Dured Dardari et al. Medicina (Kaunas). .

Abstract

Background: Cell and/or tissue-based wound care products have slowly advanced in the treatment of non-healing ulcers, however, few studies have evaluated the effectiveness of these devices in the management of severe diabetic foot ulcers.

Method: This study (KereFish) is part of a multi-national, multi-centre, randomised, controlled clinical investigation (Odin) with patients suffering from deep diabetic wounds, allowing peripheral artery disease as evaluated by an ankle brachial index equal or higher than 0.6. The study has parallel treatment groups: Group 1 treatment with Kerecis® Omega3 Wound™ versus Group 2 treatment with standard of care. The primary objective is to test the hypothesis that a larger number of severe diabetic ulcers and amputation wounds, including those with moderate arterial disease, will heal in 16 weeks when treated with Kerecis® Omega3 Wound™ than with standard of care.

Conclusion: This study has received the ethics committee approval of each participating country. Inclusion of participants began in March 2020 and ended in July 2022. The first results will be presented in March 2023. The study is registered in ClinicalTrials.gov as Identifier: NCT04537520.

Keywords: cell and/or tissue-based wound care products; diabetes foot ulcer; intact fish skin graft.

PubMed Disclaimer

Conflict of interest statement

All authors declare have no conflict with the study.

Figures

Figure 1
Figure 1
KereFish study design.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bommer C., Sagalova V., Heesemann E., Manne-Goehler J., Atun R., Bärnighausen T., Davies J., Vollmer S. Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030. Diabetes Care. 2018;41:963–970. doi: 10.2337/dc17-1962. - DOI - PubMed
    1. Pornet C., Bourdel-Marchasson I., Lecomte P., Eschwège E., Romon I., Fosse S., Assogba F., Roudier C., Fagot-Campagna A., ENTRED Scientific Committee Trends in the quality of care for elderly people with type 2 diabetes: The need for improvements in safety and quality (the 2001 and 2007 ENTRED Surveys) Diabetes Metab. 2011;37:152–161. doi: 10.1016/j.diabet.2011.02.001. - DOI - PubMed
    1. Gregg E.W., Li Y., Wang J., Rios Burrows N., Ali M.K., Rolka D., Williams D.E., Geiss L. Changes in diabetes-related complications in the United States, 1990–2010. N. Engl. J. Med. 2014;370:1514–1523. doi: 10.1056/NEJMoa1310799. - DOI - PubMed
    1. Fosse S., Hartemann-Heurtier A., Jacqueminet S., Ha Van G., Grimaldi A., Fagot-Campagna A. Incidence and characteristics of lower limb amputations in people with diabetes. Diabet. Med. J. Br. Diabet. Assoc. 2009;26:391–396. doi: 10.1111/j.1464-5491.2009.02698.x. - DOI - PubMed
    1. Armstrong D.G., Boulton A.J.M., Bus S.A. Diabetic foot ulcers and their recurrence. N. Engl. J. Med. 2017;376:2367–2375. doi: 10.1056/NEJMra1615439. - DOI - PubMed

Associated data